SMTL ID : 6fyl.1

X-ray structure of CLK2-KD(136-496)/CX-4945 at 1.95A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 3NG: 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid(Non-covalent)

3NG.1: 16 residues within 4Å: Chain A: L.36, G.37, E.38, G.39, F.41, V.44, A.58, K.60, V.94, F.110, E.111, L.112, L.113, L.164, V.193, D.194 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.36, A:V.44, A:A.58, A:F.110, A:F.110, A:L.164, A:V.193 Hydrogen bonds: A:L.113, A:D.194 Water bridges: A:K.60, A:F.195, A:F.195 Salt bridges: A:K.60

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kallen, J. et al., X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome. ChemMedChem (2018)

Release Date

2018-07-18

Peptides

Dual specificity protein kinase CLK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity protein kinase CLK2

Related Entries With Identical Sequence